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Functional tricuspid regurgitation (FTR) is 
commonly associated with left-sided heart 
disease, and it occurs secondary to tricuspid 
annular dilatation, which develops as a result of 
pulmonary hypertension [1]. Re-operative 
surgery for symptomatic tricuspid regurgitation 
after mitral valve surgery was associated with 
high 
mortality rates up to 32%, and the 5-year survival 
rate was less than 50% [2]. 
Most of the studies on the FTR investigated the 
role of concomitant tricuspid (TV) repair at the 
time of the initial mitral valve surgery in the 
presence of severe FTR. The aim of concomitant 
tricuspid valve repair is the prevention of 
progression of tricuspid regurgitation (TR) and 
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Abstract 
Background: Management of moderate functional tricuspid regurgitation (FTR) 
secondary to left-sided valve lesion is controversial. The objective of this study was 
to compare the short-term results of surgical repair versus conservative treatment 
for moderate functional tricuspid regurgitation in concomitant with mitral valve 
surgery. 
Methods: Our study included 60 patients with mitral valve lesion and moderate 
functional tricuspid regurgitation. Patients were divided into 2 groups; group A 
included 30 patients whose tricuspid valve disease were managed conservatively, 
and group B included 30 patients who had tricuspid valve band annuloplasty.  
Results: Preoperative clinical and echocardiographic data were comparable 
between groups. There was no difference regarding mechanical ventilation time (6 
.13 ± 3.02 vs. 7.01 ± 4.14 hours; p= 0.291), or intensive care unit stay (51.42 ± 12.1 
vs. 52.31 ± 15.32 hours; p=0.614) in group A and B respectively. There was a 
significant improvement in the degree of tricuspid valve regurgitation in group B 
early postoperative (moderate tricuspid regurgitation reported in 22 (73.3%) vs. 4 
(13.3%); p<0.001) and at 3 months (moderate tricuspid regurgitation 11 (36.7%) vs. 
2 (6.7%); p<0.001) and 6 months follow up (moderate tricuspid regurgitation 10 
(30%) vs.  2 (6.7%); p<0.001) in group A and B respectively. After 6-months, 20 
(66.7%) patients in group A had dyspnea grade I compared to 26 (86.7%) patients in 
group B; p=0.021. 
Conclusion: Although the correction of the left-sided lesion improved the degree of 
TR in some patients, concomitant repair of the tricuspid valve could produce better 










right-side heart failure, and the current 
recommendation is to repair severe TR; however, 
moderate TR is controversial [3]. 
The aim of our research was to compare the 
effect of TV repair versus the conservative 
treatment for patients with moderate secondary 
TR on the prevention of subsequent progression of 
tricuspid regurgitation and right ventricular failure 
in the early postoperative period. 
Patients and Methods: 
Patients population: 
This study included 60 patients with severe 
mitral valve pathology and moderate secondary 
tricuspid regurgitation who were operated upon 
between January 2016 and January 2019 for 
elective primary mitral valve surgery. 
Patients were divided into 2 groups; group A 
included 30 patients who were managed 
conservatively, and group B included 30 patients 
who had tricuspid valve band annuloplasty. 
Patients who had concomitant cardiac surgery as 
aortic valve replacement or coronary artery 
bypass grafting, patients with primary pulmonary 
hypertension, re-operative cases, emergency 
surgery, or other associated co-morbidities 
(autoimmune diseases, renal impairment, and 
hepatic decompensation) were excluded from the 
study. 
Preoperative parameters: 
All patients were subjected to complete 
history taking including the New York Heart 
Association (NYHA) classification for dyspnea, full 
clinical examination including cardiac 
examination, routine laboratory tests, plain chest 
x-ray, ECG, echocardiography with detailed 
assessment of severity of tricuspid regurgitation, 
measurement of tricuspid annulus diameter, 
tricuspid annular plane systolic excursion (TAPSE), 
myocardial Performance Index (MPI), and  
pulmonary artery pressure. 
Surgical technique: 
All patients had mitral valve surgery through a 
median sternotomy and cardioplegia arrest and 
hypothermic cardiopulmonary bypass (CPB). The 
mitral valve was replaced or repaired through a 
left atriotomy incision along the interatrial groove. 
Patients in group B were subjected to tricuspid 
valve annuloplasty through right atriotomy using a 
Gore-Tex® band (W. L. Gore & Associates, Elkton, 
Maryland, USA) or a pericardial band treated with 
glutaraldehyde 0.6% and folded on itself. The used 
band was 6 cm long and 0.5 cm wide. We have 
used 5 or 6 2/0 polypropylene sutures to plicate 
the annulus after passing them through the band.
Table 1: Comparison of the preoperative data between both groups. Continuous variables are presented as mean and 
standard deviation and categorical variables as number and percent. 
Variables Group B (n = 30) Group A (n = 30) P- value 
Age (year) 45.110.5 44.112. 18 0.751 
Gender (M/F) 11/19 12/18 0.284 
NYHA 
Class I 4 (13.3%) 0 (0%) 
0.161 Class II 8 (26.7%) 7 (23.3%) 
Class III 1 8 (60%) 23 (76.7%) 
Mitral valve regurgitation 8 (26.7%) 7 (23.3%) 
0.172 Mitral valve stenosis 18 (60%) 20 (66.7%) 
Double mitral lesion 4 (13.3%) 3 (10 %) 
EF (%) 61.404.61 62.204.91 0.391 
LAD (cm) 6.30.72 5.800.68 0.181 
LVED (cm) 5.560.61 5.350.64 0.624 
PAP (mmHg) 46.9015.03 44.0316.95 0.160 
RVD (cm) 2.220.41 2.140.47 0.093 
EF: ejection fraction; LAD: left atrial dimension; LVED: left ventricular end-diastolic diameter; PAP: pulmonary 
artery pressure; RVD: right ventricular diameter 





Table 2: Comparison of the operative and postoperative variables between groups. Continuous variables are presented 
as mean and standard deviation and categorical variables as number and percent 
Variables  Group B (n = 30)  Group A (n = 30) P value 
Bypass time (minutes) 97.5130.2 82.0121.40 0.011 
Cross-clamp time (minutes) 62.8218.52 60.1114.54 0.245 
Mechanical ventilation (hours) 7.01 ± 4.14 6 .13 ± 3.02 0.291 
ICU stay time (hours) 52.31 ± 15.32 51.42 ± 12.1 0.614 
Atrial fibrillation 2 (6.7%) 1 (3.3%) 0.554 
Bleeding 3 (10.0%) 2 (6.7%) 0.640 
Re-sternotomy 2 (6.7%) 1 (3.3%) 0.554 
No or Trivial TR 14 (46.7%) 0 <0.001 
Mild TR 12 (40.0%) 8 (26.7%) 
Moderate TR 4 (13.3%) 22 (73.3%) 
ICU:  intensive care unit; TR: tricuspid regurgitation 
The intraoperative assessment was done using a 
saline test and then trans-esophageal 
echocardiography (TEE) after coming off bypass 
Operative parameters: 
These included CPB, aortic cross-clamp times, 
weaning problems from CPB, and any 
intraoperative complications. 
Postoperative parameters: 
These included immediate postoperative 
parameters and data at 3- and 6-months period. 
Early data included; time of mechanical 
ventilation, mean arterial blood pressure, central 
venous pressure, inotropic support, the need for 
pulmonary vasodilators (milrinone or 
dobutamine, or sildenafil), amount of bleeding, 
ICU stay and the pre-discharge echocardiography 
with a detailed assessment of the right side. 
All patients were evaluated at 3- and 6-months 
interval clinically for dyspnea and right-side heart 
failure and with echocardiography with the 
assessment of the degree of tricuspid valve 
regurgitation, the diameter of the tricuspid valve 
annulus, tricuspid annular plane systolic excursion 
(TAPSE), myocardial performance index (MPI) and 
pulmonary artery pressure. 
Statistical Analysis 
Data were analyzed using IBM SPSS software 
package version 20.0 (IBM Corp, Belmont, Calf, 
USA). Continuous variables were presented as 
mean and standard deviation and categorical 
variables as number and percent. Categorical data 
were compared using Chi-square (x2) or Fisher 
exact test when appropriate and continuous data 




The mean age in group A was 45.1 ± 10.5 years, 
and 44.1 ± 12.18 in group B (p=0.735). In group A, 
11 patients (36.7%) had sinus rhythm, and 19 
patients (63.3 %) had atrial fibrillation (AF). In 
group B, 10 patients (30.9%) had sinus rhythm and 
20 patients (66.7%) had AF (p= 0.787). 
Preoperative variables are presented in Table 1.  
Intraoperative data: 
Total CPB time was significantly longer in 
group B; 97.51  30.2 minutes versus 82.01  
21.40 minutes in group A (P = 0.011). However, 
there was no significant difference regarding the 
cross-clamp time (62.82  18.52 versus 60.11  
14.54 minutes for group A versus B, respectively; 
P= 0.245). In group A, one patient (3.3%) required 
high support (adrenaline 150 nanogram/kg/min 
and dobutamine 15 g/kg/min).  
Early postoperative data: 
There was no significant difference between 
both groups regarding postoperative mechanical 
ventilation or ICU stay times. Early postoperative 
complications were non-significant between both 
groups. Tricuspid regurgitation was more 
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Table 3: Comparison of the postoperative outcomes after 3 months. Continuous variables are presented as mean and 
standard deviation and categorical variables as number and percent. 
Group B (n=30) Group A (n=30) P-value 
NYHA 
Class I 26 (86.7%) 19 (63.3%) 
0.041 Class II 1 (3.4%) 7 (23.3%) 
Class III 0 4 (13.3%) 
TR 
No or Trivial 17 (58.6%) 3 (10%) 
<0.001 
Mild 9 (30%) 14 (46.7%) 
Moderate 2 (6.7%) 11 (36.7%) 
More than Moderate 1 (3.3%) 2 (6.7%) 
EF (%) 67.30 ± 2.72 65.50± 2.40 0.147 
LAD (cm) 5.29± 0.45 5.21± 0.38 0.712 
LVED (cm) 5.12± 0.54 5.07± 0.52 0.621 
PAP (mmHg) 32.60± 5.74 31.8± 7.2 0.821 
RVD (cm) 2.07± 0.41 2.12± 0.53 0.054 
EF: ejection fraction; LAD: left atrial dimension; LVED: left ventricular end-diastolic diameter; PAP: pulmonary 
artery pressure; RVD: right ventricular diameter; TR: tricuspid regurgitation 
Follow-up data: 
After 3-months follow-up, both groups have 
shown improvement in the functional NYHA class. 
Group B showed more improvement in the degree 
of TR with a statistically highly significant 
difference (Table 3). Follow-up data after 6 
months are shown in Table 4.  
Discussion 
Patients with more than moderate tricuspid 
regurgitation should have concomitant repair 
during mitral valve surgery. However, the 
management of moderate tricuspid regurgitation 
secondary to left side valve lesions is 
controversial. In this study, we compared the 
outcome of mitral valve surgery with concomitant 
moderate tricuspid in patients who had tricuspid 
valve repair versus those who had conservative 
management. Rheumatic patients presented the 
majority of our patients, which is not well 
presented in the literature [4, 5]. Atrial fibrillation 
is commonly associated with mitral valve disease. 
Song and coworkers reported that 37.5% of their 
patients had AF before surgery, 22.2% of them 
underwent a concomitant maze
Table 4: Comparison of the postoperative outcomes after 3 months. Continuous variables are presented as mean and 
standard deviation and categorical variables as number and percent 
Group B (n=30) Group A (n=30) P-value 
NYHA 
Class I 26 (86.7%) 20 (66.7%) 
0.021 Class II 1 (3.4%) 7 (23.3%) 
Class III 0 3 (10%) 
TR 
No or Trivial 19 (66.5%) 5 (16.7%) 
<0.001 Mild 8 (26.7 %) 14 (46.7%) 
Moderate 2 (6.7%) 10 (30%) 
More than moderate 0 1 (6.7%) 
EF (%) 5.270.34 5.180.36 0.147 
LAD (cm) 5.120.54 5.030.55 0.561 
LVED (cm) 27.65.80 28.67.9 0.582 
PAP (mmHg) 2.060.34 2.100.50 0.521 
RVD (cm) 5.270.34 5.180.36 0.081 
EF: ejection fraction; LAD: left atrial dimension; LVED: left ventricular end-diastolic diameter; PAP: pulmonary 





procedure [6]. In addition, Chikwe and colleagues 
reported that patients with concomitant TVR were 
almost twice as likely to have a history of AF 
compared with patients in the isolated mitral 
valve group [7]. 
In our operative results, we found that the CPB 
time was significantly longer in group B, and this 
was attributed to the time given for tricuspid 
repair. The cross-clamp time was not significantly 
different as the tricuspid repair was done after the 
removal of the cross-clamp. These data were 
similar to Pradhan and colleagues who found that 
the DeVega annuloplasty did not significantly 
prolong the cross-clamp time as compared to 
those with mitral valve replacement only [3]. 
However, Ro and colleagues reported that 
cardiopulmonary bypass and aortic cross-clamp 
times were significantly longer in the repair group 
than in the control group [8].  
Mechanical ventilation, ICU stay, and 
morbidity were not significant between both 
groups. Our results agreed with the study of 
Pradhan and coworkers [3]. Ro and colleagues 
reported that the operative mortality rate was 
1.0%. They also have found no significant 
differences in early mortality or major morbidity 
rates between both groups [9]. Chikwe and 
coworkers reported that overall operative 
mortality was 0.6% [7]. 
The difference between groups regarding the 
degree of TR became evident during the follow-
up. Similarly, Gürsoy and coworkers have studied 
66 patients with mild tricuspid insufficiency who 
underwent mitral valve replacement without 
addressing the TV and revealed that mild FTR 
might advance to moderate (24.2%) or severe 
(27.3%) grade in more than half of the patients 
[1]. Furthermore, Pradhan and colleagues studied 
43 patients with moderate functional TR who 
underwent mitral valve surgery and found that 
eleven (47.8%) patients in the DeVega group and 
only five (25%) of the non-repair group had a trace 
or less TR with a significant difference between 
both groups [3]. 
However, Ro and colleagues studied 959 
patients with mild-to-moderate functional TR who 
underwent mitral valve surgery, with 431 of them 
offered TV repair and followed them for a median 
period of 64.6 months and concluded that 
concomitant TV repair was not associated with 
better clinical outcomes [5]. In a recent study by 
David and associates, they have found that    
preoperative moderate TR was associated with 
postoperative TR of moderate or severe degree 
after MV repair for degenerative diseases, and 
they believe that TV annuloplasty was 
appropriate in these patients [9]. 
Regarding the method of repair, Chang and 
colleagues compared the use of band versus 
suture repair and have reported that the mean TR 
grade dropped significantly after surgery, was 
maintained for up to 3 years, and increased 
gradually from 3 to 5 years postoperatively. These 
findings are similar to ours despite our short 
period of follow up. Furthermore, they have 
concluded that the mean TR improved in the band 
group and got worse in the suture group after 5 
years, and the percentage of patients with TR 
equal to or greater than grade III was higher in 
the suture group than in the band group [10]. 
We have found a significant difference in the 
functional class with better improvement in the 
repair group. Our results were supported by the 
study of Pradhan and colleagues who found that 
at three month’s review after surgery, four 
patients were in NYHA II amongst those without 
tricuspid repair, whilst the rest were in NYHA I 
[3]. Additionally, DeMeester and coworkers 
reported that NYHA functional class was 
significantly better compared with preoperatively 
in all patients, at 6 months follow-up [11]. 
In agreement with our data at the three-
months follow up, Pradhan and colleagues found 
that left ventricular dimensions, left ventricular 
function, and valve prosthetic valve function 
were similar between groups [3]. 
Moreover, our 6-months follow up data were 
supported by many studies regarding the 







status. Ghanta and colleagues found that both 
bicuspidization and ring annuloplasty produced an 
effective, durable repair at 3 years 
postoperatively. Significant 3 or 4 residual TR 
occurred in 8% of patients early after operation 
for all types of annuloplasty [4]. These results are 
similar to a previous study performed by McCarthy 
and colleagues in their study of 790 patients 
where they found that 14% of patients had 3 or 4 
residual TR early after operation for all 
annuloplasty types, but ring repairs (Carpentier 
semirigid ring and Cosgrove-Edwards flexible 
band) provided a more durable repair than suture 
annuloplasty over an 8-year period [2]. 
Study limitations 
There are several limitations to this study, 
including the small sample size and short-term 
follow-up. 
Conclusion 
Although the correction of the left-sided lesion 
improved the degree of TR in some patients, 
concomitant repair of the tricuspid valve could 
produce better improvement in the clinical 
outcome when compared to the conservative 
approach. 
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